Table 7.
Treatment Regimen Phase-III non-inferiority trial | |
---|---|
Arm 1 | Day 1 |
150-mg IV Fosaprepitant | |
32-mg IV Ondansetron | |
12-mg PO Dexamethasone | |
Day 2 | |
8-mg PO Dexamethasone | |
Day 3–4 | |
16-mg PO Dexamethasone | |
Arm 2 | Day 1 |
125-mg PO Aprepitant | |
32-mg IV Ondansetron | |
12-mg PO Dexamethasone | |
Cisplatin | |
Day 2–3 | |
80-mg PO Aprepitant | |
8-mg PO Dexamethasone | |
Cisplatin | |
Day 4 | |
8-mg PO Dexamethasone |